| Date Filed | Type | Description |
| 06/06/2023 |
3
| Merendino Lauren (Director) has filed a Form 3 on ESSA Pharma Inc. |
| 01/05/2023 |
4
| Parkinson David Ross (CEO) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 21,367 shares
@ $2.39, valued at
$51.1k
Bought 3,067 shares
@ $2.6, valued at
$8k
|
|
| 01/05/2023 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Sold 25,000 shares
@ $3, valued at
$75k
Sold 32,000 shares
@ $2.9, valued at
$92.8k
Sold 50,000 shares
@ $2.86, valued at
$143k
Sold 50,000 shares
@ $2.67, valued at
$133.5k
Sold 43,617 shares
@ $2.53, valued at
$110.4k
Sold 37,889 shares
@ $2.41, valued at
$91.3k
Sold 34,334 shares
@ $2.42, valued at
$83.1k
|
|
| 01/05/2023 |
4
| Wood David S. (CFO) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 8,302 shares
@ $2.6, valued at
$21.6k
|
|
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/21/2022 |
3
| Kantoff Philip W. (Director) has filed a Form 3 on ESSA Pharma Inc. |
| 07/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Sold 25,100 shares
@ $5.8536, valued at
$146.9k
|
|
| 08/20/2021 |
4
| BIOTECH GROWTH N V (10% Owner) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Bought 250,000 shares
@ $8.8752, valued at
$2.2M
|
|
| 08/17/2021 |
3
| BIOTECH GROWTH N V (10% Owner) has filed a Form 3 on ESSA Pharma Inc. |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4/A
| ZWEIFACH SANFORD S (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Thorell Marella (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Sollis Gary (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Requadt Scott (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Martin John Alexander (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Glickman Richard M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 25,000 options to buy
@ $7, valued at
$175k
|
|
| 01/26/2021 |
4/A
| Brettman Ari David (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/11/2021 |
4
| ZWEIFACH SANFORD S (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
|